Please assess the completion status of the following clinical trial:

Trial Title: Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18 - 80 years of age,~* a single enhancing lesion of the brain with MRI appearance consistent with GBM~* Pathologic confirmation of GBM~* Zubrod Performance Scale (ZPS) \< 2~* Must be able to undergo MRI imaging with gadolinium~* Must have access to a computer and the internet (to use KetoCalculator© on-line Database)~Exclusion Criteria:~* unable to undergo MRI with gadolinium~* genetic disorders of fat metabolism~* patients receiving sodium valproate (may cause false ketone reading in urine)~* diabetes~* enrolled in another treatment trial for GBM

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ketogenic Diet (Type: EXPERIMENTAL): Subjects will adhere to a ketogenic diet prior to the start of and through radiation therapy course until the time of first scan after radiation ends. During radiation course, patients also take temozolomide daily.

Based on this trial design, predict the completion outcome and termination type (if applicable).